# JAMA December 9, 2025 issue — FDA approves GLP‑1 pill for cardiovascular risk in type 2 diabetes and other updates

**Category:** Health
**Source:** [https://jamanetwork.com/journals/jama/issue/334/22](https://jamanetwork.com/journals/jama/issue/334/22)
**Publisher:** JAMA (The Journal of the American Medical Association)
**Published:** 2025-12-09
**Scraped (UTC):** 2025-12-20T06:57:48+00:00

## Summary
The December 9, 2025 JAMA issue includes coverage of the FDA approval of an oral GLP‑1 therapy for reducing cardiovascular risk in type 2 diabetes patients, along with other clinical guidance and policy updates.

## Full Article
*(Article text could not be extracted. Visit source link above.)*

---

*Content scraped from public sources with attribution. Users assume all risk.*  
*Auto-generated by [Perplexity News Tracker](https://github.com/myidkd1-coder/perplexity-news-tracker)*